Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel Regimen

Preferred Label : Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel Regimen;

NCIt synonyms : Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel; ABCP Regimen; Tecentriq/Avastin/Carboplatin/Taxol; Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel; Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel Regimen;

NCIt related terms : ABCP; ABCP (bevacizumab-bvzr); ABCP (bevacizumab-adcd); ABCP (bevacizumab-equi); ABCP (bevacizumab-aybi); ABCP (bevacizumab-onbe); ABCP (bevacizumab-awwb); ABCP (bevacizumab-maly);

NCIt definition : A regimen consisting of atezolizumab, bevacizumab, carboplatin, and paclitaxel that can be used in the treatment of advanced non-squamous non-small cell lung cancer (NSCLC).;

NCI Metathesaurus CUI : CL936977;

Codes from synonyms : 29978; 127344; 127566; 127640; 127418; 127270; 127492; 127196;

Details

Origin ID

C157394;

UMLS CUI

C4761554;

Automatic exact mappings (from CISMeF team)
- Atp-binding cassette, subfamily g, member 2 [OMIM gene]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Atezolizumab [NCIt concept]
- Bevacizumab [NCIt concept]
- Carboplatin [NCIt concept]
- Paclitaxel [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients